Israeli firms to feature products at China Int'l Import Expo
Israeli firms in the fields of robotics, artificial intelligence (AI) and medicine will present their products at the China International Import Expo 2018 (CIIE) which kicks off in Shanghai in November.
Medical technology is a focus of the Israeli government's tech development and one of the key components of the government's four-pillar plan for developing and marketing AI.
Israel's breakthrough technologies include tumor-targeting cancer therapy and a robotic exoskeleton that enables people with paraplegia to walk.
G-Medical – remote diagnostics & patient care
G-Medical CEO Yaakov Geva has spoken with CGTN's team before leaving for CIIE. He explained how his company's devices and technology can revolutionize medical treatment in China.
G-Medical CEO Yaakov Geva in an interview with CGTN /CGTN Photo
"Think about Beijing. Think about Guangzhou or Shenzhen or any one of those cities... If you wanna go to the hospital... you will spend seven hours sitting and queuing to see a doctor for one and a half minute."
G-Medical developed a series of devices like chest patches and monitors that attach directly to cellphones. Travel to a medical facility is rendered unnecessary as patients attach devices to the body, which allows a remote treating doctor or team of physicians to gauge symptoms and vital signs and diagnose any potential medical conditions without physically seeing the patient in the clinic.
A health monitor screen of G-Medical /CGTN Photo
Ideal for China
According to G-Medical research, China's emergency rooms are at times overwhelmed with multiple patients waiting to see physicians. The devices devised by G-Medical are a solution for relieving stress from limited medical facilities and physicians.
Medical devices produced by G-Medical /CGTN Photo
China, Geva said, is an attractive market for his products because of its size and scope.
China is increasingly investing in Israel's technological development. More than a quarter of last year's two billion US dollars in funding came from China.
G-Medical is currently operating a facility in Guangzhou where the devices are in the clinical trial phase.
https://news.cgtn.com/news/3d3d414f334d6a4e7a457a6333566d54/share.html
- Forums
- ASX - By Stock
- GMV
- Ann: September Update
Ann: September Update, page-261
-
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online